A review of the endometrial changes in Norplant® users

Annals of the New York Academy of Sciences

Volumn 828, Issue , 1997, Pages 108-110

  Wan, Livia S ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVONORGESTREL;

BREAKTHROUGH BLEEDING; CONFERENCE PAPER; DECIDUALIZATION; ENDOMETRIUM; FEMALE; HEMOSTASIS; HUMAN; HYSTEROSCOPY; INTRADERMAL DRUG ADMINISTRATION; MICROVASCULATURE; SEXUAL BEHAVIOR; UTERUS BLEEDING;

EID: 0030777807     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb48528.x     Document Type: Conference Paper

References (14)

1. ® and Norplant II contraceptives. Stud. Fam. Plann. 19: 81-94.
2. SHOUPE, D., D. R. MISHELL, JR., B. L. BOPP & M. FIELDING. 1991. The significance of bleeding patterns in Norplant implant users. Obstet. Gynecol. 77: 256-260.
3. NILSSON, G. C. & P. HOLMA. 1981. Menstrual blood loss with contraceptive subdermal levonorgestrel implants. Fertil. Steril. 35: 304-306.
4. JOHANNISSON, E. 1990. Effects on the endometrium endo- and exocervix following the use of local progestogen-releasing delivery systems. Contraception 40: 403-421.
5. ® implant users. Contraception 53: 97-100.
6. CROXATTO, H. D., S. DIAZ, M. PAVEX & H. B. CROXATTO. 1984. Histopathology of the endometrium during continuous use of levonorgestrel. In Long-acting Contraceptive Delivery Systems. G. I. Zatuchni, A. Goldsmith, J. D. Shelton & J. J. Sciarra, Eds.: 290-295. Harper & Row Publishers. Philadelphia, PA.
7. HOURIHAN, H. M., B. L. SHEPPARD, E. M. BELSEY & I. A. BROSENS. 1991. Endometrial vascular features prior to and following exposure to levonorgestrel. Contraception 43: 375-385.
8. FAUNDES, A., F. ALVAREZ-SANCHES, V. BRACHE, E. JIMENEZ & A. S. TEJADA. 1991. Hormonal changes associated with bleeding during low-dose progestogen contraception delivered by Norplant subdermal implants. Adv. Contracept. 7: 85-91.
9. ROGER, P. A. W., C. L. AU & B. AFFANDI. 1993. Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel. Hum. Reprod. 8: 1396-1404.
10. GOODGER, A. M., P. A. W. ROGERS & B. AFFANDI. 1994. Endometrial endothelial cell proliferation in long-term users of subdermal levonorgestrel. Hum. Reprod. 9:1647-1651.
11. FRAZER, I. Personal communication.
12. LOCKWOOD, C. J., Y. NEMERSON, S. GULLER, et al. 1993. Progestational regulation of human endometrial stromal cell tissue factor expression during decidualization. J. Clin. Endocrinol. Metab. 76: 231-236.
13. SCHATZ, F. & C. J. LOCKWOOD. 1993. Progestin regulation of plasminogen activator inhibitor type-1 in primary cultures of endometrial stromal and decidual cells. J. Clin. Endocrinol. Metab. 77: 621-625.
14. SHWEIKI, D., A. ITIN, G. NEUFELD, H. GITAY-GOREN & E. KESHET. 1993. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J. Clin. Invest. 91:2235-2243.